TOP TIERMARKET NEWSWIRE
Movers explained · November 13, 2026

Why Is LINEAGE INC EQUITY Equity (LINE) Stock Moving Today?

By the Top Tier Newswire AI Desk · November 11, 2026 at 12:11 AM ET · reviewed against 5 wire stories

LINEAGE INC EQUITY Equity (LINE) is drawing unusual attention today. Our newswire has captured 5 stories on LINE across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Lineage (LINE) shares fell 12.05% to $34.88 as third-quarter results missed expectations and the company lowered its full-year adjusted EBITDA guidance. The decline was driven by rising fire costs and trade disruptions that pressured margins, alongside a revenue miss of $10 million.

What Happened

Lineage reported third-quarter revenue of $1.36 billion, falling short of the $1.364 billion consensus estimate. Core funds from operations came in at 73 cents per share, exceeding the 70 cent consensus, but adjusted EBITDA declined by 7%. The company updated its fiscal 2026 guidance, projecting adjusted EBITDA between $1.25 billion and $1.27 billion while targeting a leverage ratio of 5.0x to 5.5x. Management cited trade and carrier costs as primary factors pressuring Global Industrial Services margins. A Form 8-K filed on November 9, 2026, disclosed the preliminary results and financial statements. Barclays maintained its Sell rating on the stock following the announcement.

What The Data Shows

The stock printed 25 fresh 52-week lows on November 10, 2026, following a single fresh 52-week high earlier in the year. The current price sits within the 52-week range of $31.33 to $45.75. Lineage has a market capitalization of $8.9 billion and remains unprofitable with a trailing twelve-month EPS of negative $0.72. Revenue grew 1.0% over the trailing twelve months, while the net margin stands at negative 3.1%. The stock carries a beta of 0.85 and a dividend yield of 5.44%. A dividend of $0.5325 per share was paid with an ex-date of September 30, 2026. Recent insider activity includes one buy totaling $988,000, with the most recent transaction on September 1, 2026. Kevin Patrick Marchetti, a co-executive, purchased shares on August 28, 2026.

What To Watch

Investors will monitor how the revised 2026 adjusted EBITDA guidance of $1.25 billion to $1.27 billion impacts future valuation multiples. The company’s target leverage range of 5.0x to 5.5x will be a key metric as it navigates ongoing trade and carrier cost pressures.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

LINE by the numbers

Coverage: 5 stories / 4 sourcesAI sentiment: 58/100 (bullish)Mkt cap: $8.9B52w: $31.33 to $45.75
LINE · Nov 11 session (5-min) · +1.49% vs prior close · updated 8:49 PM ET
$34.50$35.10$35.70prev close $34.88$35.408:35 AM10:32 AM12:30 PM2:27 PM4:25 PM8:35 AM · $35.409:10 AM · $35.609:30 AM · $34.719:35 AM · $34.959:40 AM · $35.069:45 AM · $35.059:50 AM · $35.099:55 AM · $35.1610:00 AM · $34.8710:05 AM · $34.7710:10 AM · $34.7010:15 AM · $34.8210:20 AM · $34.5710:25 AM · $34.6610:30 AM · $34.6410:35 AM · $34.6410:40 AM · $34.6310:45 AM · $34.6610:50 AM · $34.8010:55 AM · $34.8211:00 AM · $34.9111:05 AM · $34.8011:10 AM · $34.8511:15 AM · $35.0011:20 AM · $34.9411:25 AM · $34.9311:30 AM · $34.9811:35 AM · $35.0311:40 AM · $34.9511:45 AM · $34.9911:50 AM · $35.0511:55 AM · $35.0712:00 PM · $35.1712:05 PM · $35.2212:10 PM · $35.1612:15 PM · $35.1012:20 PM · $35.1612:25 PM · $35.0612:30 PM · $35.0912:35 PM · $34.8412:40 PM · $34.8812:45 PM · $34.8512:50 PM · $34.9212:55 PM · $34.861:00 PM · $34.881:05 PM · $34.941:10 PM · $34.991:15 PM · $35.011:20 PM · $34.991:25 PM · $35.021:30 PM · $35.011:35 PM · $35.031:40 PM · $35.001:45 PM · $34.951:50 PM · $34.951:55 PM · $34.932:00 PM · $34.852:05 PM · $34.882:10 PM · $34.862:15 PM · $34.892:20 PM · $35.022:25 PM · $35.052:30 PM · $35.122:35 PM · $35.132:40 PM · $35.182:45 PM · $35.132:50 PM · $35.262:55 PM · $35.413:00 PM · $35.463:05 PM · $35.473:10 PM · $35.443:15 PM · $35.493:20 PM · $35.523:25 PM · $35.483:30 PM · $35.553:35 PM · $35.623:40 PM · $35.633:45 PM · $35.573:50 PM · $35.333:55 PM · $35.404:00 PM · $35.404:20 PM · $35.404:25 PM · $35.40
AI sentiment, last 36h · averaged over 5 stories · 58/100 bullish
AI sentiment 58/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 5 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agonowGuruFocus · sentiment 42 · Lineage Inc (LINE) (Q3 2026) Earnings Call Highlights: Occupancy Gains Offset by Seafood Slump and Fire CostsGuruFocus · 42Lineage Inc (LINE) (Q3 2026) Earnings Call Highlights: Occupancy Gains Offset by Seafood …StockTitan · sentiment 64 · Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s DiseaseStockTitan · 64Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for …Seeking Alpha · sentiment 58 · Lineage expects cash runway into Q2 2028 while adding HUNT1 Phase Ib/IIa Huntington’s programSeeking Alpha · 58Lineage expects cash runway into Q2 2028 while adding HUNT1 Phase Ib/IIa Huntington’s pro…The Fly · sentiment 63 · Lineage price target raised to $37 from $36 at Piper SandlerThe Fly · 63Lineage price target raised to $37 from $36 at Piper SandlerGuruFocus · sentiment 63 · LINE Maintained by Piper Sandler -- Price Target Raised to $37.00GuruFocus · 63LINE Maintained by Piper Sandler -- Price Target Raised to $37.00
10h agoGuruFocusBULLISH 63Analyst

LINE Maintained by Piper Sandler -- Price Target Raised to $37.00

14h agoThe FlyBULLISH 63Analyst

Lineage price target raised to $37 from $36 at Piper Sandler

18h agoSeeking AlphaBULLISH 58Product/PR

Lineage expects cash runway into Q2 2028 while adding HUNT1 Phase Ib/IIa Huntington’s program

Lineage Cell Therapeutics adds HUNT1 for Huntington’s through NeuroAirmid and expects funding into Q2 2028, one quarter earlier.

1d agoStockTitanBULLISH 64M&A

Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease

1d agoGuruFocusBEARISH 42Earnings

Lineage Inc (LINE) (Q3 2026) Earnings Call Highlights: Occupancy Gains Offset by Seafood Slump and Fire Costs

Frequently asked questions

Why is LINE stock moving today?

LINEAGE INC EQUITY Equity (LINE) is drawing unusual attention today. Our newswire has captured 5 stories on LINE across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "LINE Maintained by Piper Sandler -- Price Target Raised to $37.00" (GuruFocus).

Is LINE a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of LINE coverage reads 58/100 over 5 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.

More moves explained today

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on LINE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier LINE move explainers: 2026-11-11 · 2026-11-10